Capabilities
Our Digital Health group guides companies through the myriad considerations they encounter as the delivery of healthcare becomes increasingly digital.
As private equity investment in the Life Sciences and Healthcare industry continues to increase, our cohesive regulatory and transactional approach helps ensure success through each phase of investment.
We provide 360-degree support to companies that develop, manufacture and distribute products tailored specifically toward improving women’s health, from start-ups to global corporations.
Our Sunshine and State Law Compliance Group serves as a powerful industry advocate with respect to transparency laws for more than 100 members companies.
We established the Surprise Billing and Price Transparency Group to assist our clients in developing solutions to changes in healthcare transparency laws.
The K&S International Ad Hoc Group is a coalition of 20+ pharma and medical device companies that focuses on international transparency/disclosure laws targeting manufacturers.
January 21, 2025
Health Headlines January 21, 2025
January 13, 2025
Health Headlines January 13, 2025
January 10, 2025
FDA Releases Draft Guidance on Submission Recommendations for AI-Enabled Device Software Functions
January 29, 2025
Cory Hohnbaum and Andy Bayman represent Boehringer Ingelheim in a Zantac-related trial before an Illinois state court
January 27, 2025
Kyle Gotchy discusses President Trump’s federal funding freeze and how it may impact the DEA’s recent proposed rule
January 27, 2025
Liv Kiser and Michael Resch represent Beech-Nut Nutrition and Walmart before a California federal court in a dispute involving heavy metals in baby food